STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection

Journal of Clinical Investigation

Volumn 125, Issue 6, 2015, Pages 2347-2362

  Desvignes, Ludovic ^a   Weidinger, Carl ^a   Shaw, Patrick ^a   Vaeth, Martin ^a   Ribierre, Theo ^a   Liu, Menghan ^a   Fergus, Tawania ^a   Kozhaya, Lina ^a   McVoy, Lauren ^a   Unutmaz, Derya ^a   Ernst, Joel D ^a   Feske, Stefan ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 3; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPILIN 1; NUCLEAR RECEPTOR NUR77; RANTES; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; STROMAL INTERACTION MOLECULE 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CALCIUM CHANNEL; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; STIM1 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BONE MARROW CELL; CALCIUM TRANSPORT; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DOWN REGULATION; GENE DELETION; GENE EXPRESSION PROFILING; IMMUNOREGULATION; LOSS OF FUNCTION MUTATION; LUNG TUBERCULOSIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOID CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CHRONIC DISEASE; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MICROBIOLOGY; PATHOLOGY;

ANIMALS; CALCIUM CHANNELS; CELL DIFFERENTIATION; CHRONIC DISEASE; CYTOKINES; IMMUNITY, CELLULAR; INFLAMMATION; MICE; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS, PULMONARY;

EID: 84930393456     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI80273     Document Type: Article

References (88)

1. Feske S, Wulff H, Skolnik EY. Ion channels in innate and adaptive immunity. Annu Rev Immunol. 2015;33: 291-353.
2. Feske S, Skolnik EY, Prakriya M. Ion channels and transporters in lymphocyte function and immunity. Nat Rev Immunol. 2012;12(7): 532-547.
3. Shaw PJ, Weidinger C, Vaeth M, Luethy K, Kaech SM, Feske S. CD4+ and CD8+ T cell-dependent antiviral immunity requires STIM1 and STIM2. J Clin Invest. 2014 124(10): 4549-4563.
4. Weidinger C, Shaw PJ, Feske S. STIM1 and STIM2-mediated Ca(2+) influx regulates antitumour immunity by CD8(+) T cells. EMBO Mol Med. 2013;5(9): 1311-1321.
5. Feske S. CRAC channelopathies. Pflugers Arch. 2010;460(2): 417-435.
6. Feske S. Immunodeficiency due to defects in store-operated calcium entry. Ann N Y Acad Sci. 2011;1238: 74-90.
7. Feske S, et al. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol. 1996;26(9): 2119-2126.
8. Le Deist F, et al. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood. 1995;85(4): 1053-1062.
9. Partiseti M, Le Deist F, Hivroz C, Fischer A, Korn H, Choquet D. The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem. 1994;269(51): 32327-32335.
10. Feske S, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006;441(7090): 179-185.
11. Picard C, et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med. 2009;360(19): 1971-1980.
12. Byun M, et al. Whole-exome sequencingbased discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med. 2010;207(11): 2307-2312.
13. McCarl CA, et al. ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol. 2009;124(6): 1311-1318.
14. Srivastava S, Ernst JD, Desvignes L. Beyond macrophages: The diversity of mononuclear cells in tuberculosis. Immunol Rev. 2014;262(1): 179-192.
15. Wolf AJ, et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med. 2008;205(1): 105-115.
16. Urdahl KB. Understanding and overcoming the barriers to T cell mediated immunity against tuberculosis. Semin Immunol. 2014;26(6): 578-587.
17. Nunes-Alves C, Booty MG, Carpenter SM, Jayaraman P, Rothchild AC, Behar SM. In search of a new paradigm for protective immunity to TB. Nat Rev Microbiol. 2014;12(4): 289-299.
18. Bold TD, Ernst JD. CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J Immunol. 2012;189(5): 2530-2536.
19. Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol. 2012;7: 353-384.
20. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon ? gene-disrupted mice. J Exp Med. 1993;178(6): 2243-2247.
21. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon ? in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178(6): 2249-2254.
22. Dupuis S, et al. Human interferon-?-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev. 2000;178: 129-137.
23. Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol. 2012;12(2): 136-148.
24. Dorhoi A, Kaufmann SH. Perspectives on host adaptation in response to Mycobacterium tuberculosis: Modulation of inflammation. Semin Immunol. 2014;26(6): 533-542.
25. Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J Immunol. 2011;186(3): 1598-1607.
26. Lenardo M, et al. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol. 1999;17: 221-253.
27. Kulinski JM, Tarakanova VL, Verbsky J. Regulation of antiviral CD8 T-cell responses. Crit Rev Immunol. 2013;33(6): 477-488.
28. Murphy FJ, Hayes I, Cotter TG. Targeting inflammatory diseases via apoptotic mechanisms. Curr Opin Pharmacol. 2003;3(4): 412-419.
29. Veiga-Parga T, Sehrawat S, Rouse BT. Role of regulatory T cells during virus infection. Immunol Rev. 2013;255(1): 182-196.
30. Smigiel KS, Srivastava S, Stolley JM, Campbell DJ. Regulatory T-cell homeostasis: Steady-state maintenance and modulation during inflammation. Immunol Rev. 2014;259(1): 40-59.
31. Larson RP, Shafiani S, Urdahl KB. Foxp3(+) regulatory T cells in tuberculosis. Adv Expe Med Biology. 2013;783: 165-180.
32. Oh-Hora M, et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol. 2008;9(4): 432-443.
33. Waite JC, et al. Interference with Ca(2+) release activated Ca(2+) (CRAC) channel function delays T-cell arrest in vivo. Eur J Immunol. 2013;43(12): 3343-3354.
34. Kim KD, Srikanth S, Yee MK, Mock DC, Lawson GW, Gwack Y. ORAI1 deficiency impairs activated T cell death and enhances T cell survival. J Immunol. 2011;187(7): 3620-3630.
35. Denis M, Gregg EO, Ghandirian E. Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. Int J Immunopharmacol. 1990;12(7): 721-727.
36. Desvignes L, Wolf AJ, Ernst JD. Dynamic roles of Type I and Type II IFNs in early infection with Mycobacterium tuberculosis. J Immunol. 2012;188(12): 6205-6215.
37. Feske S, Draeger R, Peter HH, Eichmann K, Rao A. The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells. J Immunol. 2000;165(1): 297-305.
38. McCarl CA, et al. Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J Immunol. 2010;185(10): 5845-5858.
39. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferongamma production by IL-12 and IL-18. Curr Opin Immunol. 1998;10(3): 259-264.
40. Feng CG, et al. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol. 2005;174(7): 4185-4192.
41. Kiani A, et al. Regulation of interferon-? gene expression by nuclear factor of activated T cells. Blood. 2001;98(5): 1480-1488.
42. Macian F. NFAT proteins: Key regulators of T-cell development and function. Nat Rev Immunol. 2005;5(6): 472-484.
43. Rengarajan J, Tang B, Glimcher LH. NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naive T(H)cells. Nat Immunol. 2002;3(1): 48-54.
44. Zhang M, Gong J, Presky DH, Xue W, Barnes PF. Expression of the IL-12 receptor β1 and β2 subunits in human tuberculosis. J Immunol. 1999;162(4): 2441-2447.
45. van Rietschoten JG, et al. Silencer activity of NFATc2 in the interleukin-12 receptor β 2 proximal promoter in human T helper cells. J Biol Chem. 2001;276(37): 34509-34516.
46. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol. 2005;6(4): 353-360.
47. Bolacchi F, et al. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol. 2006;144(2): 188-196.
48. Wohlfert E, Belkaid Y. Role of endogenous and induced regulatory T cells during infections. J Clin Immunol. 2008;28(6): 707-715.
49. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8(7): 523-532.
50. Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor? Immunity. 2009;30(5): 626-635.
51. Weiss JM, et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med. 2012;209(10): 1723-1742.
52. Thornton AM, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184(7): 3433-3441.
53. Yadav M, et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med. 2012;209(10): 1713-1722.
54. Chang JH, Kim YJ, Han SH, Kang CY. IFN-gamma- STAT1 signal regulates the differentiation of inducible Treg: Potential role for ROS-mediated apoptosis. Eur J Immunol. 2009;39(5): 1241-1251.
55. Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol. 2001;2(4): 316-324.
56. Bold TD, Banaei N, Wolf AJ, Ernst JD. Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo. PLoS Pathog. 2011;7(5): E1002063.
57. Prochazkova J, Pokorna K, Holan V. IL-12 inhibits the TGF-beta-dependent T cell developmental programs and skews the TGF-beta-induced differentiation into a Th1-like direction. Immunobiology. 2012;217(1): 74-82.
58. Holtz-Heppelmann CJ, Algeciras A, Badley AD, Paya CV. Transcriptional regulation of the human FasL promoter-enhancer region. J Biol Chem. 1998;273(8): 4416-4423.
59. Hodge S, Novembre FJ, Whetter L, Gelbard HA, Dewhurst S. Induction of fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14. Virology. 1998;252(2): 354-363.
60. Xanthoudakis S, et al. An enhanced immune response in mice lacking the transcription factor NFAT1. Science. 1996;272(5263): 892-895.
61. Heyer J, et al. Inefficient termination of antigen responses in NF-ATp-deficient mice. Immunobiology. 1997;198(1-3): 162-169.
62. Rengarajan J, et al. Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity. 2000;12(3): 293-300.
63. Ranger AM, Oukka M, Rengarajan J, Glimcher LH. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity. 1998;9(5): 627-635.
64. Turner J, et al. CD8- And CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Biol. 2001;24(2): 203-209.
65. Wang Q, Zhou Y, Weiss HL, Chow CW, Evers BM. NFATc1 regulation of TRAIL expression in human intestinal cells. PLoS One. 2011;6(5): E19882.
66. Morra M, Zubiaur M, Terhorst C, Sancho J, Malavasi F. CD38 is functionally dependent on the TCR/CD3 complex in human T cells. FASEB J. 1998;12(7): 581-592.
67. Youn HD, Sun L, Prywes R, Liu JO. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science. 1999;286(5440): 790-793.
68. Vaeth M, et al. Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A. 2012;109(40): 16258-16263.
69. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008;9(2): 194-202.
70. Josefowicz SZ, et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature. 2012;482(7385): 395-399.
71. Hawwari A, Burrows J, Vadas MA, Cockerill PN. The human IL-3 locus is regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-specific activities. J Immunol. 2002;169(4): 1876-1886.
72. Oh-Hora M, et al. Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. Immunity. 2013;38(5): 881-895.
73. Fuchs S, et al. Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J Immunol. 2012;188(3): 1523-1533.
74. Bopp T, et al. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells. J Exp Med. 2005;201(2): 181-187.
75. Beyersdorf N, et al. STIM1-independent T cell development and effector function in vivo. J Immunol. 2009;182(6): 3390-3397.
76. Gwack Y, et al. Hair loss and defective T- And B-cell function in mice lacking ORAI1. Mol Cell Biol. 2008;28(17): 5209-5222.
77. Kakeda M, et al. Heat-killed bacillus Calmette- Guerin and Mycobacterium kansasii antigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells. Br J Dermatol. 2012;166(5): 953-963.
78. Schoenborn JR, Wilson CB. Regulation of interferon- gamma during innate and adaptive immune responses. Adv Immunol. 2007;96: 41-101.
79. Lee DU, Avni O, Chen L, Rao A. A distal enhancer in the interferon-gamma (IFNγ) locus revealed by genome sequence comparison. J Biol Chem. 2004;279(6): 4802-4810.
80. Sakai S, Mayer-Barber KD, Barber DL. Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis. Curr Opin Immunol. 2014;29: 137-142.
81. Lin AA, Tripathi PK, Sholl A, Jordan MB, Hildeman DA. Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production. J Virol. 2009;83(17): 8604-8615.
82. Barber DL, Andrade BB, Sereti I, Sher A. Immune reconstitution inflammatory syndrome: The trouble with immunity when you had none. Nat Rev Microbiol. 2012;10(2): 150-156.
83. Shtrichman R, Samuel CE. The role of ? interferon in antimicrobial immunity. Curr Opin Microbiol. 2001;4(3): 251-259.
84. Grundy S, et al. CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patients. Clin Sci. 2014;126(3): 223-232.
85. Banaiee N, Kincaid EZ, Buchwald U, Jacobs WR Jr, Ernst JD. Potent inhibition of macrophage responses to IFNγ by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol. 2006;176(5): 3019-3027.
86. Wolf AJ, et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol. 2007;179(4): 2509-2519.
87. Desvignes L, Ernst JD. Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity. 2009;31(6): 974-985.
88. Wan Q, et al. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells. J Exp Med. 2011;208(9): 1875-1887.